This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Event: 2306

Key Event Title

A descriptive phrase which defines a discrete biological change that can be measured. More help

Persistent vaginal cornification

Short name
The KE short name should be a reasonable abbreviation of the KE title and is used in labelling this object throughout the AOP-Wiki. More help
PVC
Explore in a Third Party Tool

Biological Context

Structured terms, selected from a drop-down menu, are used to identify the level of biological organization for each KE. More help
Level of Biological Organization
Tissue

Organ term

The location/biological environment in which the event takes place.The biological context describes the location/biological environment in which the event takes place.  For molecular/cellular events this would include the cellular context (if known), organ context, and species/life stage/sex for which the event is relevant. For tissue/organ events cellular context is not applicable.  For individual/population events, the organ context is not applicable.  Further information on Event Components and Biological Context may be viewed on the attached pdf. More help
Organ term
epithelium of vagina

Key Event Components

The KE, as defined by a set structured ontology terms consisting of a biological process, object, and action with each term originating from one of 14 biological ontologies (Ives, et al., 2017; https://aopwiki.org/info_pages/2/info_linked_pages/7#List). Biological process describes dynamics of the underlying biological system (e.g., receptor signalling).Biological process describes dynamics of the underlying biological system (e.g., receptor signaling).  The biological object is the subject of the perturbation (e.g., a specific biological receptor that is activated or inhibited). Action represents the direction of perturbation of this system (generally increased or decreased; e.g., ‘decreased’ in the case of a receptor that is inhibited to indicate a decrease in the signaling by that receptor).  Note that when editing Event Components, clicking an existing Event Component from the Suggestions menu will autopopulate these fields, along with their source ID and description.  To clear any fields before submitting the event component, use the 'Clear process,' 'Clear object,' or 'Clear action' buttons.  If a desired term does not exist, a new term request may be made via Term Requests.  Event components may not be edited; to edit an event component, remove the existing event component and create a new one using the terms that you wish to add.  Further information on Event Components and Biological Context may be viewed on the attached pdf. More help
Process Object Action
cornification epithelium of vagina occurrence

Key Event Overview

AOPs Including This Key Event

All of the AOPs that are linked to this KE will automatically be listed in this subsection. This table can be particularly useful for derivation of AOP networks including the KE.Clicking on the name of the AOP will bring you to the individual page for that AOP. More help
AOP Name Role of event in AOP Point of Contact Author Status OECD Status
Decreased GnRH release leading to increased E2 AdverseOutcome Martina Panzarea (send email) Under development: Not open for comment. Do not cite

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KE.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available in relation to this KE. More help
Term Scientific Term Evidence Link
mammals mammals NCBI

Life Stages

An indication of the the relevant life stage(s) for this KE. More help
Life stage Evidence
Adult, reproductively mature

Sex Applicability

An indication of the the relevant sex for this KE. More help
Term Evidence
Female

Key Event Description

A description of the biological state being observed or measured, the biological compartment in which it is measured, and its general role in the biology should be provided. More help

Biological state

The rodent cycle is subdivided in four subsequent phases, proestrous, estrous, metestrous (or diestrous 1) and diestrous (or dioestrous 2).  It is characterized by hormonal variation and consequent behavioural, morphological and physiological changes to the reproductive tract (ovary, uterus and vagina), describing these four phases.  Proestrous is the period during which pre-ovulatory development of the follicles takes place in the ovary. Estrous is the brief interval during which the female accepts the male and during which ovulation occurs. Next is metoestrous, the early luteal phase, followed by diestrous. The duration of the estrous cycle of rodent strains most commonly used in toxicology studies is typically 4 to 5 days (Goldman, 2007). For each phase of the cycle, the ovary, uterus and vagina have typical morphologic characteristics (Dixon, 2014).

Biological role in physiology

The keratinization of vaginal epithelial cells (vaginal cornification) that typically characterizes the day of estrous in the cycling rodents, is a consequence of the rising level of estradiol that peaks around midday on proestrous (Goldman, 2007).

Repeated failure of ovulation over successive days produces irregular cycles characterized by a persistent vaginal cornification (PVC). This state is called persistent estrous or constant estrous. Females in persistent estrous exhibit constant sexual receptivity (Westwood, 2008). The term persistent estrous (PE) in adult rats denotes failure of at least two consecutive estrous cycles as documented by cornified vaginal smears for 10 or more days (Singh, 2005).

Exposure to estrogenic compounds has commonly been reported to result in a persistent vaginal cornification (Goldman, 2007). As such, persistent vaginal cornification represents a good marker of prolonged E2 bioavailability in the uterus in regulatory studies.

It is noteworthy that persistent estrous is not equivalent to the true estrous phase. Indeed, at ovary level, estrous stage is characterized by the presence of new basophilic corpora lutea (CP) formed after the current ovulation and an absence of healthy (non-atretic) tertiary follicles. On the other end, a state of persistent estrous is characterized by ovaries with absence of basophilic corpora lutea, increased number of antral follicles and follicular cysts. Persistent estrous is comparable with the anovulatory cycles in women (Horvath 2004; Finch, 2014).

How It Is Measured or Detected

A description of the type(s) of measurements that can be employed to evaluate the KE and the relative level of scientific confidence in those measurements.These can range from citation of specific validated test guidelines, citation of specific methods published in the peer reviewed literature, or outlines of a general protocol or approach (e.g., a protein may be measured by ELISA). Do not provide detailed protocols. More help

Regular cyclicity is one of the key parameters in assessment of female reproductive function in rodents. Parameters assessed for cyclicity:

  • Number of cycling females
  • Number of females with regular cycles
  • Number of cycles
  • Estrous cycle length
  • Percentage of time spent in the various estrous cycle stages. Abnormal cycles were defined as one or more estrous cycles in the 21-day period with prolonged estrous (≥3 days) or prolonged diestrous (≥4 days) within a given cycle (Goldman, 2007).

Visual assessment

Visual observation of the vagina is the fastest method. It requires no special equipment and is best used when only proestrous or estrous stages need to be identified. It is non-invasive but the findings from this technique are observer-dependent. In the proestrous phase, the vaginal opening appears full, swollen and moist (Ajayi, 2020). The vaginal opening of mice in proestrous is characterized by swollen, moist, pink tissue. The opening is wide and there are often wrinkles or striations along the dorsal and ventral edges. As the mouse enters estrous, the vaginal opening becomes less pink, less moist, and less swollen (Byers, 2012).

Vaginal smear

Estrous cycle can be monitored in the rat and mouse by observing the changes in the vaginal smear cytology. It seems to be the most common technique used to determine the phases of the estrous cycle. It is non-invasive and relatively inexpensive (Goldman, 2007; Byer, 2012; Ajayi, 2020) and OECD guidelines (www.oecd.org).

The estrous phase shows abundant non-nucleate cornified epithelial cells. The cytoplasm is granular, and the cells are irregular in shape. Persistent estrous is characterized by cornified vaginal smears for 10 or more days.

Monitoring of estrous cyclicity is included in OECD test guidelines (TG 421: Reproduction/Developmental Toxicity Screening Test, 2016; TG 422 Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test, 2016; TG 416: Two-Generation Reproduction Toxicity, 2001; TG 443: Extended One-Generation Reproductive Toxicity Study, 2018; and in USA EPA OCSPP 890.1450. Pubertal Development and Thyroid Function in Intact Juvenile/Peripubertal Female Rats Assay, 2011.

Histological examination of the reproductive organs

This technique is invasive and does not allow individual estrous cyclicity assessment. The minimal requirement for estrous staging evaluation by histology is the complete longitudinal sections of the vagina and cervix, transverse sections of the mid-portion of both uterine horns, and middle sections of both ovaries (Goldman 2007; Byers, 2012). Persistent estrous is characterized in ovary by the presence of numbers of ovarian follicular cysts (due to pre-ovulatory follicles losing the capacity to ovulate) absence of basophilic corpora lutea and decreased corpora lutea while uterine epithelium becomes tall columnar and vagina may show cornification (Westwood, 2008, Dixon, 2014, Shirai 2017, see also Fig. 16).

In OECD TG 443: For adult P and F1 females, a vaginal smear is examined on the day of necropsy to determine the stage of the estrous cycle and allow correlation with histopathology in reproductive organs.  Vaginal smear at necropsy is also required in OECD TG 408, OECD TG 421, OECD TG 422 while it is optional in OECD TG 407.

Other methods

Vaginal wall impedance and urine biochemistry are alternative methods. However, no standard values are available for commonly used laboratory animals (Ajayi, 2020).

Domain of Applicability

A description of the scientific basis for the indicated domains of applicability and the WoE calls (if provided).  More help

The majority of the information comes from in vivo studies with rodents.

Regulatory Significance of the KE

While an evaluation of the estrous cycle in laboratory rodents can be a useful measure of the integrity of the hypothalamic-pituitary-ovarian reproductive axis, it can also serve as a way of ensuring that animals exhibiting abnormal cycling patterns are excluded from a study prior to exposure to a test compound. When incorporated as an adjunct to other endpoint measures, a determination of a female's cycling status can contribute important information about the nature of a toxicant insult to the reproductive system. In doing so, it can help to integrate the data into a more comprehensive mechanistic portrait of the effect, and in terms of risk assessment, may provide some indication of a toxicant's impact on human reproductive physiology. Significant evidence that the estrous cycle (or menstrual cycle in primates) has been disrupted should be considered an adverse effect (OECD, 2008). Included should be evidence of abnormal cycle length or pattern, ovulation failure, or abnormal menstruation (AOP 7).

Regulatory Significance of the Adverse Outcome

An AO is a specialised KE that represents the end (an adverse outcome of regulatory significance) of an AOP. More help

References

List of the literature that was cited for this KE description. More help

Ajayi AF and Akhigbe RE, 2020. Staging of the estrous cycle and induction of estrus in experimental rodents: an update. Fertil Res Pract, 6:5. doi: 10.1186/s40738-020-00074-3

Byers SL, Wiles MV, Dunn SL and Taft RA, 2012. Mouse estrous cycle identification tool and images. PLoS One, 7:e35538. doi: 10.1371/journal.pone.0035538

Dixon D, Alison R, Bach U, Colman K, Foley GL, Harleman JH, Haworth R, Herbert R, Heuser A, Long G, Mirsky M, Regan K, Van Esch E, Westwood FR, Vidal J and Yoshida M, 2014. Nonproliferative and proliferative lesions of the rat and mouse female reproductive system. J Toxicol Pathol, 27:1s-107s. doi: 10.1293/tox.27.1S

Finch CE, 2014. The menopause and aging, a comparative perspective. J Steroid Biochem Mol Biol, 142:132-141. doi: 10.1016/j.jsbmb.2013.03.010

Goldman JM, Murr AS and Cooper RL, 2007. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol, 80:84-97. doi: 10.1002/bdrb.20106

Horvath JE, Toller GL, Schally AV, Bajo AM and Groot K, 2004. Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats. Proc Natl Acad Sci U S A, 101:4996-5001. doi: 10.1073/pnas.0400605101

OECD, 2007. Test No. 440: Uterotrophic Bioassay in Rodents : A short-term screening test for oestrogenic properties.

OECD, 2009. Environment Directorate, Series on testing and assessment number 106. Guidance document for histologic evaluation of endocrine and reproductive tests in rodents. Part 3. Section 2. ENDOCRINE CONTROL OF THE OESTROUS CYCLE. In: OECD series on testing and assessment. . Paris, OECD Publishing.

OECD, 2018a. Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption.

OECD, 2018b. Test No. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents.

Shirai N, Houle C and Mirsky ML, 2015. Using Histopathologic Evidence to Differentiate Reproductive Senescence from Xenobiotic Effects in Middle-aged Female Sprague-Dawley Rats. Toxicol Pathol, 43:1158-1161. doi: 10.1177/0192623315595137

Singh KB, 2005. Persistent estrus rat models of polycystic ovary disease: an update. Fertil Steril, 84 Suppl 2:1228-1234. doi: 10.1016/j.fertnstert.2005.06.013

Westwood FR, 2008. The female rat reproductive cycle: a practical histological guide to staging. Toxicol Pathol, 36:375-384. doi: 10.1177/0192623308315665